Cargando…

Association between radiotherapy and risk of second primary malignancies in patients with resectable lung cancer: a population-based study

BACKGROUND: The most common form of treatment for non-metastatic lung cancer is surgery-based combination therapy, which may also include adjuvant radiotherapy or chemotherapy. Second primary malignancies (SPMs) are uncommon but significant radiation side effects in patients with resectable lung can...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Bolun, Zang, Ruochuan, Song, Peng, Zhang, Moyan, Bie, Fenglong, Bai, Guangyu, Li, Yuan, Huai, Qilin, Han, Yuning, Gao, Shugeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827664/ https://www.ncbi.nlm.nih.gov/pubmed/36624443 http://dx.doi.org/10.1186/s12967-022-03857-y

Ejemplares similares

Worldwide burden and epidemiological trends of tracheal, bronchus, and lung cancer: A population-based study
por: Zhou, Bolun, et al.
Publicado: (2022)

A new N descriptor for non-small cell lung cancer: the classification based on anatomic location, number and ratio of metastatic lymph nodes
por: Zhou, Bolun, et al.
Publicado: (2022)

Utility of (18)F-FDG uptake in predicting major pathological response to neoadjuvant immunotherapy in patients with resectable non‑small cell lung cancer
por: Chen, Xiaowei, et al.
Publicado: (2023)

Global burden and temporal trends in incidence and mortality of oesophageal cancer
por: Zhou, Bolun, et al.
Publicado: (2022)

RNA modification writer expression profiles predict clinical outcomes and guide neoadjuvant immunotherapy in non-small cell lung cancer
por: Zhou, Bolun, et al.
Publicado: (2022)

Research Progress of Anti-PD-1/PD-L1 Immunotherapy Related Mechanisms and Predictive Biomarkers in NSCLC
por: Bie, Fenglong, et al.
Publicado: (2022)

Comprehensive analysis of PD-L1 expression, tumor-infiltrating lymphocytes, and tumor microenvironment in LUAD: differences between Asians and Caucasians
por: Bie, Fenglong, et al.
Publicado: (2021)

Single‐cell RNA sequencing analysis reveals transcriptional heterogeneity of multiple primary lung cancer
por: Guo, Wei, et al.
Publicado: (2023)

TIGIT/CD47 dual high expression predicts prognosis and is associated with immunotherapy response in lung squamous cell carcinoma
por: Peng, Yue, et al.
Publicado: (2022)

Multimodal analysis of cell-free DNA whole-methylome sequencing for cancer detection and localization
por: Bie, Fenglong, et al.
Publicado: (2023)

Consolidation Tumor Ratio Combined With Pathological Features Could Predict Status of Lymph Nodes of Early-Stage Lung Adenocarcinoma
por: Zhao, Liang, et al.
Publicado: (2022)

Clinicopathological characteristics and prognostic factors of primary pulmonary lymphoma
por: He, Huayu, et al.
Publicado: (2021)

Primary pulmonary epithelioid malignant peripheral nerve sheath tumor in a child: a case report
por: Zhang, Moyan, et al.
Publicado: (2020)

Comprehensive analysis of the immunological implication and prognostic value of CXCR4 in non-small cell lung cancer
por: Guo, Wei, et al.
Publicado: (2022)

Elevated Heterogeneous Nuclear Ribonucleoprotein C Expression Correlates With Poor Prognosis in Patients With Surgically Resected Lung Adenocarcinoma
por: Guo, Wei, et al.
Publicado: (2021)

The surgical management of early-stage lung adenocarcinoma: is wedge resection effective?
por: Ji, Ying, et al.
Publicado: (2021)

Pseudogene PHBP1 promotes esophageal squamous cell carcinoma proliferation by increasing its cognate gene PHB expression
por: Feng, Feiyue, et al.
Publicado: (2017)

Comprehensive Analysis of Clinical Significance, Immune Infiltration and Biological Role of m(6)A Regulators in Early-Stage Lung Adenocarcinoma
por: Zhou, Bolun, et al.
Publicado: (2021)

Second primary malignancy risk after radiotherapy in rectal cancer survivors
por: Wang, Ti-Hao, et al.
Publicado: (2018)

Carbon-ion radiotherapy in the treatment of radiation-induced second primary malignancies
por: Yang, Jing, et al.
Publicado: (2022)

Second Malignant Neoplasms Following Radiotherapy
por: Kumar, Sanath
Publicado: (2012)

Feasibility of stereotactic radiotherapy for lung lesions and conventional radiotherapy for nodal areas in primary lung malignancies
por: Kim, Yeon Joo, et al.
Publicado: (2018)

Risk of second primary malignancies in head and neck cancer patients treated with definitive radiotherapy
por: Ng, Sweet Ping, et al.
Publicado: (2019)

Radiotherapy was associated with the lower incidence of metachronous second primary lung cancer
por: Hu, Zhi Gang, et al.
Publicado: (2019)

Wedge resection is equal to segmental resection for pulmonary typical carcinoid patients at localized stage: a population-based analysis
por: Yan, Tao, et al.
Publicado: (2019)

Clinical Outcomes of Patients with Resected Oral Cavity Cancer and Simultaneous Second Primary Malignancies
por: Liao, Chun-Ta, et al.
Publicado: (2015)

Second Primary Lung Adenocarcinoma After Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma
por: Xue, Fen, et al.
Publicado: (2022)

Integrating microarray-based spatial transcriptomics and single-cell RNA-sequencing reveals tissue architecture in esophageal squamous cell carcinoma
por: Guo, Wei, et al.
Publicado: (2022)

Pan-Cancer Analysis of FURIN as a Potential Prognostic and Immunological Biomarker
por: Zhou, Bolun, et al.
Publicado: (2021)

Association of Radiotherapy for Rectal Cancer and Second Gynecological Malignant Neoplasms
por: Guan, Xu, et al.
Publicado: (2021)

Successful Radiotherapy of Primary Malignant Peripheral Nerve Sheath Tumor of the Lung
por: Yanagisawa, Katsuya, et al.
Publicado: (2022)

Prognostic outcome after second primary lung cancer in patients with previously treated lung cancer by radiotherapy
por: Wu, Yijun, et al.
Publicado: (2020)

Second primary malignancies after treatment for malignant lymphoma
por: Okines, A, et al.
Publicado: (2005)

Multiple primary lung cancer: Updates of clinical management and genomic features
por: Tian, He, et al.
Publicado: (2023)

Translational value of IDH1 and DNA methylation biomarkers in diagnosing lung cancers: a novel diagnostic panel of stage and histology-specificity
por: Zang, Ruochuan, et al.
Publicado: (2019)

Comprehensive analysis of suppressor of cytokine signaling 2 protein in the malignant transformation of NSCLC
por: Ma, Guoyuan, et al.
Publicado: (2023)

Surgical resection for second primary colorectal cancer: a population-based study
por: Li, Ting, et al.
Publicado: (2023)

Identification of prognostic genes and tumor-infiltrating immune cells in the tumor microenvironment of esophageal squamous cell carcinoma and esophageal adenocarcinoma
por: Huai, Qilin, et al.
Publicado: (2021)

Second Primary Cancer after Radiotherapy for Cervical Cancer
por: Jhamad, Sushma, et al.
Publicado: (2018)

Survival analysis of breast cancer patients after diagnosis of second primary malignancies, focusing on the second primary hematologic malignancy
por: Kim, Hyung Jin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jro6llc8huuvpfbbvv8tlvqss1